论文部分内容阅读
马海治瘫丸是我院内科神经组自拟的复方(由马钱子、海风藤、黄芪、当归、大黄等药组成)。1982-1984年临床观察,治疗中风50例,中风后遗症30例,总有效率为96%和80%,其中痊愈率、基本痊愈率为38%及17%。我组实验表明本方能使麻醉狗、猫脑血流量显著增加,脑血管阻力显著降低。为了进一步探讨临床作用原理,我们对动物体内血栓形成及体外血小板聚集性进行了研究。实验方法及其结果一、制剂:将药剂科生产的马海治瘫丸制
The Mahai Zhiqi Pill is a compound prepared by the neurology group in our hospital (composed of Maqinzi, Haifengteng, Huangqi, Chinese angelica, rhubarb and other drugs). From 1982 to 1984, clinical observations were made on 50 cases of stroke and 30 cases of stroke sequelae. The total effective rates were 96% and 80%, and the cure rate and basic cure rate were 38% and 17%. My group of experiments showed that this side can significantly increase cerebral blood flow in anesthetized dogs and cats, and significantly reduce cerebral vascular resistance. In order to further explore the principle of clinical action, we studied thrombosis in vivo and platelet aggregation in vitro. Experimental methods and results I. Formulations: Production of Mahai Zhiyu Pills produced by the Department of Pharmacy